UAE Contract Manufacturing Organizations Market, By Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging), By End User (Big Pharmaceuticals, Small and Mid-Size Pharmaceuticals, Generic Pharmaceutical Companies, Others), By Region, Competition Forecast & Opportunities, 2027
UAE Contract Manufacturing Organizations market is expected to register robust growth in the forecast period, 2023-2027. Contract manufacturing organizations offer highly valuable services to enhance the production capacities of the pharmaceutical industry. The escalating demand for pharmaceutical products for the treatment of numerous diseases and the rise in the need for outsourcing manufacturing operations is propelling the market growth. CMOs follow numerous regulations imposed by the government and comprises highly skilled manpower, a cost-effective service portfolio, and presence of the state of the art manufacturing facilities. The expanding competition in the pharmaceutical sector has accelerated the need for the introduction of pharmacy products as early as possible to hold the leading position in the market. With this, the increasing pricing pressure and rising benefits offered by the CMOs including high-quality products at standard cost and minimized timelines are significantly inducing the growth of the market during the forecast years.
Significant Growth in the Biologics Market Fuels the Market Growth
The rising prevalence of several chronic diseases, such as cancer, and the escalating demand for effective therapies are augmenting the market growth. The growing investments in the development of complex biologic molecules and the inflating need for a proficient service provider that delivers products as per the regulatory standards. The biological molecules are referred to as complex and to manufacture these products strong skills and approved manufacturing facilities are required. CMOs are focusing to enhance their capabilities to fulfill the increasing needs, thereby more and more biologics products are being outsourced for packaging and manufacturing activities. This, in turn, is driving the growth of the market. Growing production capacities by the leading CROs are projected to uplift the pharmaceutical CMO market in the upcoming years.
The emergence of CMOs with Growing Production Capacities Promotes the Market Growth
The growing demand for outsourcing and the entry of various novel manufacturing companies with advanced solutions are augmenting the growth of the market. Leading pharmaceutical players are believing in their technical capabilities and can outsource their production to the service provider. Several small and mid-sized pharmaceutical companies are engaging with one or more CMOs which is driving market growth. The expanding number of contract manufacturing organizations entering this particular zone is expected to offer lucrative growth opportunities to the key market players.
Market Segmentation
UAE contract manufacturing organizations market is segmented into type, end user, regional distribution, and competitive landscape. Based on type, the market is divided into active pharmaceutical ingredients (API) manufacturing, finished dosage formulation (FDF) development & manufacturing, and secondary packaging. Based on end users, the market is segmented into big pharmaceuticals, small and mid-size pharmaceuticals, generic pharmaceutical companies, and others. To analyze the market based on the region, the UAE contract manufacturing organizations market is studied in major regions namely Dubai, Abu Dhabi, Sharjah, Rest of UAE.
Market Players
Life Pharma FZE, Pharmax Pharmaceuticals FZ-LLC, Julphar Pharmaceuticals, Vieco Pharmaceuticals FZCO, ADCAN Pharma, Neopharma Pharmaceuticals, and Pharma Solutions are the key market players operating in UAE Contract Manufacturing Organizations market.
Report Scope:
In this report, UAE Contract Manufacturing Organizations market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in UAE Contract Manufacturing Organizations market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Significant Growth in the Biologics Market Fuels the Market Growth
The rising prevalence of several chronic diseases, such as cancer, and the escalating demand for effective therapies are augmenting the market growth. The growing investments in the development of complex biologic molecules and the inflating need for a proficient service provider that delivers products as per the regulatory standards. The biological molecules are referred to as complex and to manufacture these products strong skills and approved manufacturing facilities are required. CMOs are focusing to enhance their capabilities to fulfill the increasing needs, thereby more and more biologics products are being outsourced for packaging and manufacturing activities. This, in turn, is driving the growth of the market. Growing production capacities by the leading CROs are projected to uplift the pharmaceutical CMO market in the upcoming years.
The emergence of CMOs with Growing Production Capacities Promotes the Market Growth
The growing demand for outsourcing and the entry of various novel manufacturing companies with advanced solutions are augmenting the growth of the market. Leading pharmaceutical players are believing in their technical capabilities and can outsource their production to the service provider. Several small and mid-sized pharmaceutical companies are engaging with one or more CMOs which is driving market growth. The expanding number of contract manufacturing organizations entering this particular zone is expected to offer lucrative growth opportunities to the key market players.
Market Segmentation
UAE contract manufacturing organizations market is segmented into type, end user, regional distribution, and competitive landscape. Based on type, the market is divided into active pharmaceutical ingredients (API) manufacturing, finished dosage formulation (FDF) development & manufacturing, and secondary packaging. Based on end users, the market is segmented into big pharmaceuticals, small and mid-size pharmaceuticals, generic pharmaceutical companies, and others. To analyze the market based on the region, the UAE contract manufacturing organizations market is studied in major regions namely Dubai, Abu Dhabi, Sharjah, Rest of UAE.
Market Players
Life Pharma FZE, Pharmax Pharmaceuticals FZ-LLC, Julphar Pharmaceuticals, Vieco Pharmaceuticals FZCO, ADCAN Pharma, Neopharma Pharmaceuticals, and Pharma Solutions are the key market players operating in UAE Contract Manufacturing Organizations market.
Report Scope:
In this report, UAE Contract Manufacturing Organizations market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- UAE Contract Manufacturing Organizations Market, By Type:
- Active Pharmaceutical Ingredients (API) Manufacturing
- Finished Dosage Formulation (FDF) Development & Manufacturing
- Secondary Packaging
- UAE Contract Manufacturing Organizations Market, By End User:
- Big Pharmaceuticals
- Small and Mid-Size Pharmaceuticals
- Generic Pharmaceutical Companies
- Others
- UAE Contract Manufacturing Organizations Market, By Region:
- Dubai
- Abu Dhabi
- Sharjah
- Rest of UAE
Company Profiles: Detailed analysis of the major companies present in UAE Contract Manufacturing Organizations market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE CONTRACT MANUFACTURING ORGANIZATIONS MARKET
4. VOICE OF CUSTOMER
5. EXECUTIVE SUMMARY
6. UAE CONTRACT MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging)
6.2.2. By End User (Big Pharmaceuticals, Small and Mid-Size Pharmaceuticals, Generic Pharmaceutical Companies, Others)
6.2.3. By Company (2021)
6.2.4. By Region
6.3. Product Market Map
7. UAE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By End User
8. UAE FINISHED DOSAGE FORMULATION (FDF) DEVELOPMENT & MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By End User
9. UAE FINISHED SECONDARY PACKAGING MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. UAE ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Life Pharma FZE
14.2. Pharmax Pharmaceuticals FZ-LLC
14.3. Julphar Pharmaceuticals
14.4. Vieco Pharmaceuticals FZCO
14.5. ADCAN Pharma
14.6. Neopharma Pharmaceuticals
14.7. Pharma Solutions
15. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE CONTRACT MANUFACTURING ORGANIZATIONS MARKET
4. VOICE OF CUSTOMER
5. EXECUTIVE SUMMARY
6. UAE CONTRACT MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging)
6.2.2. By End User (Big Pharmaceuticals, Small and Mid-Size Pharmaceuticals, Generic Pharmaceutical Companies, Others)
6.2.3. By Company (2021)
6.2.4. By Region
6.3. Product Market Map
7. UAE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By End User
8. UAE FINISHED DOSAGE FORMULATION (FDF) DEVELOPMENT & MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By End User
9. UAE FINISHED SECONDARY PACKAGING MANUFACTURING ORGANIZATIONS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. UAE ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Life Pharma FZE
14.2. Pharmax Pharmaceuticals FZ-LLC
14.3. Julphar Pharmaceuticals
14.4. Vieco Pharmaceuticals FZCO
14.5. ADCAN Pharma
14.6. Neopharma Pharmaceuticals
14.7. Pharma Solutions
15. STRATEGIC RECOMMENDATIONS
